Stock Evaluator: Encompass Health Corporation (EHC)

Encompass Health Corporation EHC

$111.07 0.18 0.16%
July 31, 2026 4:00:02 PM EST November 10, 2021 Volume: 503,672
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Providers & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Commentary & Analysis


Financial Summary

Share Statistics EHC Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $11,018.0 $1,742.7 79%
Shares Out (Mil) 100.6 76.7 62%
Institutional Ownership 99.0% 89.7% 84%
Float (Mil) 97.9 49.4 61%
Beta 0.60 0.82 34%
Avg Daily Volume (000s) 689 521 64%
Price Change
(52-week)
1.0% 78.7% 46%
Growth EHC Industry
Median
Percentile
(All Stocks)
Sales (5yr) 10.7% 11.0% 61%
Net Income (5yr) 14.8% (0.7%) 62%
EPS (5yr) 14.2% 3.1% 54
Dividends (5yr) (8.5%) 0.0% 74%
Cash Flow (5yr) (16.3%) (18.0%) 44%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 12 13 13
Current EPS $1.480 $6.005 $6.537
Month Ago EPS $1.479 $6.008 $6.538
# Rev Up 2 2 1
# Rev Down 0 0 0
Three Months Ago EPS $1.476 $5.931 $6.490
Year/Year Chg (16.6%) 8.2% 30.0%
Financials EHC Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $6,066 $1,456 77%
Net Income (TTM) (Mil) $609 $12 81%
EPS (TTM) $6.065 $0.300 89%
Operating Cash Flow (TTM) (Mil) $1,200 $138 83%
Net Cash Flow (TTM) (Mil) $41 $8 69%
Long-Term Debt (Q1) (Mil) $2,720 $316 78%
Enterprise Value (Q1) (Mil) $14,310 $2,170 79%
Valuation EHC Industry
Median
Percentile
(All Stocks)
P/B 4.38 2.85 75%
P/E 19.0 26.7 48%
Dividend Yield 0.7% 0.0% 64%
PEG (5yr hist) 0.8 1.1 38%
Ratios EHC Industry
Median
Percentile
(All Stocks)
Gross Margin 43.5% 27.8% 54%
Net Margin 10.0% 1.1% 63%
ROA 8.7% 1.8% 85%
ROE 26.0% 7.1% 85%
Liabilities to Assets 54.0% 59.9% 46%
F-Score 8 5 94%

Passing Stock Screens

As of 7/31/2026, from a list of 60 stock screening strategies, EHC meetings the criteria of 1 screen:

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors